Minimal manifestation status and prednisone withdrawal in the MGTX trial

OBJECTIVE: To examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients with myasthenia gravis (MG). METHODS: This study is a post hoc analysis of data from a randomized trial of thymectomy in MG (Thymectomy Trial...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neurology
Главные авторы: Lee, Ikjae, Kuo, Hui-Chien, Aban, Inmaculada B., Cutter, Gary R., McPherson, Tarrant, Kaminski, Henry J., Sussman, Jon, Ströbel, Philipp, Oger, Joel, Cea, Gabriel, Heckmann, Jeannine M., Evoli, Amelia, Nix, Wilfred, Ciafaloni, Emma, Antonini, Giovanni, Witoonpanich, Rawiphan, King, John O., Beydoun, Said R., Chalk, Colin H., Barboi, Alexandru C., Amato, Anthony A., Shaibani, Aziz I., Katirji, Bashar, Lecky, Bryan R.F., Buckley, Camilla, Vincent, Angela, Dias-Tosta, Elza, Yoshikawa, Hiroaki, Waddington-Cruz, Marcia, Pulley, Michael T., Rivner, Michael H., Kostera-Pruszczyk, Anna, Pascuzzi, Robert M., Jackson, Carlayne E., Verschuuren, Jan J.G., Massey, Janice M., Kissel, John T., Werneck, Lineu C., Benatar, Michael, Barohn, Richard J., Tandan, Rup, Mozaffar, Tahseen, Conwit, Robin, Minisman, Greg, Sonett, Joshua R., Wolfe, Gil I.
Формат: Artigo
Язык:Inglês
Опубликовано: Lippincott Williams & Wilkins 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7455358/
https://ncbi.nlm.nih.gov/pubmed/32611638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000010031
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы